A survey of the production of plasma derivatives for clinical use.
D000991:Antithrombins / Q000032:analysis; D001779:Blood Coagulation Factors; D001798:Blood Proteins / Q000032:analysis; D002056:Burns / Q000628:therapy; D002802:Cholinesterases / Q000097:blood; D003168:Complement Fixation Tests; D003460:Crystallization; D006801:Humans; D007106:Immune Sera / Q000302:isolation & purification; D007070:Immunoglobulin A; D007141:Immunoglobulin Fc Fragments; D007075:Immunoglobulin M; D007136:Immunoglobulins; D010434:Pepsin A / Q000494:pharmacology; D010920:Placenta / Q000032:analysis; D010958:Plasminogen / Q000032:analysis; D011549:Pseudomonas / Q000276:immunology; D012204:Rh-Hr Blood-Group System; D012709:Serum Albumin / Q000302:isolation & purification; D013742:Tetanus / Q000276:immunology
D000991:Antithrombins; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D007106:Immune Sera; D007070:Immunoglobulin A; D007141:Immunoglobulin Fc Fragments; D007075:Immunoglobulin M; D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System; D012709:Serum Albumin; D010958:Plasminogen; D002802:Cholinesterases; D010434:Pepsin A